Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d'essais randomisés contrôlés.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Volume: 66

Issue: 10

Year of Publication: 2021

Affiliated Institutions:  Western Sydney University, NICM Health Research Institute, Westmead, Australia. Deakin University, IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia. The Professorial Unit, The Melbourne Clinic; Department of Psychiatry, University of Melbourne, Melbourne, Australia. School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Center for Brain Research, Medical University of Vienna, Spitalgasse, Wien, Austria. University of Toronto and Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Division of Pharmacology, Center of Excellence for Pharmaceutical Sciences, School of Pharmacy, North West University, Potchefstroom, South Africa. College of Science, Health, Engineering and Education, Murdoch University, Perth, Australia. Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Depression Research Unit, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. University of British Columbia, Vancouver, Canada.

Abstract summary 

Plant-based medicines have had a long-standing history of use in psychiatric disorders. Highly quantified and standardized extracts or isolates may be termed "phytoceuticals," in a similar way that medicinal nutrients are termed as "nutraceuticals." Over the past 2 decades, several meta-analyses have examined the data for a range of plant-based medicines in the treatment of psychiatric disorders. The aim of this international project is to provide a "meta-review" of this top-tier evidence.We identified, synthesized, and appraised all available up to date meta-analyses... of randomized controlled trials (RCTs) reporting on the efficacy and effectiveness of individual phytoceuticals across all major psychiatric disorders.Our systematic search identified 9 relevant meta-analyses of RCTs, with primary analyses including outcome data from 5,927 individuals. Supportive meta-analytic evidence was found for St John's wort for major depressive disorder (MDD); curcumin and saffron for MDD or depression symptoms, and ginkgo for total and negative symptoms in schizophrenia. Kava was not effective in treating diagnosed anxiety disorders. We also provide details on 22 traditional Chinese herbal medicine formulas' meta-analyses (primarily for depression studies), all of which revealed highly significant and large effect sizes. Their methodology, reporting, and potential publication bias were, however, of marked concern. The same caveat was noted for the curcumin, ginkgo, and saffron meta-analyses, which may also have significant publication bias.More rigorous international studies are required to validate the efficacy of these phytoceuticals before treatment recommendations can be made. In conclusion, the breadth of data tentatively supports several phytoceuticals which may be effective for mental disorders alongside pharmaceutical, psychological therapies, and standard lifestyle recommendations.

Authors & Co-authors:  Sarris Jerome J Marx Wolfgang W Ashton Melanie M MM Ng Chee H CH Galvao-Coelho Nicole N Ayati Zahra Z Zhang Zhang-Jin ZJ Kasper Siegfried S Ravindran Arun A Harvey Brian H BH Lopresti Adrian A Mischoulon David D Amsterdam Jay J Yatham Lakshmi N LN Berk Michael M

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177.
Authors :  15
Identifiers
Doi : 10.1177/0706743720979917
SSN : 1497-0015
Study Population
Male,Female
Mesh Terms
Anxiety Disorders
Other Terms
Chinese herbal medicine;anxiety;clinical trials;depression;herbal medicine;mental disorders;mental health;nutraceutical;psychiatry;schizophrenia;treatment
Study Design
Randomized Control Trial,Cross Sectional Study
Study Approach
Systemic Review
Country of Study
Publication Country
United States